SignalXSignalX

LIVN LivaNova PLC

Q3 2025 10-Q
Filed: Nov 5, 2025Period ending Sep 30, 2025
Health Care
Electromedical & Electrotherapeutic ApparatusSEC EDGAR
LivaNova PLC Overview

LivaNova PLC (LIVN) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 5, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Risk Factors

  • • No new or changed risk factors disclosed since most recent 10-K, control procedures unchanged
  • • Disclosure controls effective as of September 30, 2025, per CEO and CFO evaluation
+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$358M

Net Income

$27M

Gross Margin

68.4%

Operating Margin

15.1%

Net Margin

7.5%

ROE

2.3%

Total Assets

$2.6B

Source: XBRL data from LivaNova PLC Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Get deeper insights on LivaNova PLC

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.